BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22901196)

  • 1. Who are the breast cancer survivors in Malaysia?
    Ibrahim NI; Dahlui M; Aina EN; Al-Sadat N
    Asian Pac J Cancer Prev; 2012; 13(5):2213-8. PubMed ID: 22901196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive factors for supraclavicular lymph node recurrence in N1 breast cancer patients.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(4):2509-14. PubMed ID: 23725165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hospital volume on breast cancer outcome: a population-based study in the Netherlands.
    Siesling S; Tjan-Heijnen VC; de Roos M; Snel Y; van Dalen T; Wouters MW; Struikmans H; van der Hoeven JJ; Maduro JH; Visser O
    Breast Cancer Res Treat; 2014 Aug; 147(1):177-84. PubMed ID: 25106659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    Sinha AK; Patel JR; Shen Y; Ueno NT; Giordano SH; Tripathy D; Lopez DS; Barcenas CH
    PLoS One; 2017; 12(1):e0170081. PubMed ID: 28085940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
    Wong SM; King T; Boileau JF; Barry WT; Golshan M
    Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival rates and predictors of survival among colorectal cancer patients in a Malaysian tertiary hospital.
    Magaji BA; Moy FM; Roslani AC; Law CW
    BMC Cancer; 2017 May; 17(1):339. PubMed ID: 28521746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.
    Wen J; Ye F; Huang X; Li S; Yang L; Xiao X; Xie X
    Tumour Biol; 2016 Jun; 37(6):7493-500. PubMed ID: 26678892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre.
    Mohd Taib NA; Yip CH; Mohamed I
    Asian Pac J Cancer Prev; 2008; 9(2):197-202. PubMed ID: 18712958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lymphangiogenesis and lymphovascular invasion on the survival pattern of breast cancer patients.
    Sahoo PK; Jana D; Mandal PK; Basak S
    Asian Pac J Cancer Prev; 2014; 15(15):6287-93. PubMed ID: 25124613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor response ratio predicts overall survival in breast cancer patients treated with neoadjuvant chemotherapy.
    Miller M; Ottesen RA; Niland JC; Kruper L; Chen SL; Vito C
    Ann Surg Oncol; 2014 Oct; 21(10):3317-23. PubMed ID: 25059788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the National Cancer Data Base.
    Greif JM; Pezzi CM; Klimberg VS; Bailey L; Zuraek M
    Ann Surg Oncol; 2012 Oct; 19(10):3199-204. PubMed ID: 22766989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Male breast cancers behave differently in elderly patients.
    Tural D; Selçukbiricik F; Aydoğan F; Beşe N; Yetmen O; Ilvan Ş; Büyükünal E; Serdengeçti S
    Jpn J Clin Oncol; 2013 Jan; 43(1):22-7. PubMed ID: 23159765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Postmastectomy Radiotherapy and Survival Rates for Breast Cancer Patients with T1-T2 and One to Three Positive Lymph Nodes.
    Huo D; Hou N; Jaskowiak N; Winchester DJ; Winchester DP; Yao K
    Ann Surg Oncol; 2015 Dec; 22(13):4295-304. PubMed ID: 25820998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia.
    Alcantara VS; Lim GH; Lim SH; Sultana R; Lee JA
    J Surg Oncol; 2017 Apr; 115(5):523-537. PubMed ID: 28168712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
    Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
    Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
    Fu J; Wu L; Jiang M; Li D; Jiang T; Hong Z; Wang F; Li S
    PLoS One; 2016; 11(10):e0164921. PubMed ID: 27760180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.
    Seneviratne S; Lawrenson R; Scott N; Kim B; Shirley R; Campbell I
    PLoS One; 2015; 10(4):e0123523. PubMed ID: 25849101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.